Immunosuppression in cardiac graft rejection: A human in vitro model to study the potential use of new immunomodulatory drugs

Experimental Cell Research

Volumn 314, Issue 6, 2008, Pages 1337-1350

  Crescioli, Clara ^a   Squecco, Roberta ^a   Cosmi, Lorenzo ^a   Sottili, Mariangela ^a   Gelmini, Stefania ^a   Borgogni, Elisa ^a   Sarchielli, Erica ^a   Scolletta, Sabino ^b   Francini, Fabio ^a   Annunziato, Francesco ^a   Vannelli, Gabriella Barbara ^a   Serio, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Allograft rejecton; Cardiomyocytes; CXCL10; Immunosuppressors

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CYCLOSPORIN A; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; ROSIGLITAZONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FETUS; FLOW CYTOMETRY; GAP JUNCTION; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

EID: 40049087871     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.12.016     Document Type: Article

References (58)

1. J.A. Kobashigawa J.K. Patel Immunosuppression for heart transplantation: where are we now? Nat. Clin. Pract. Cardiovasc. Med. 3 2006 203 212
2. P.F. Halloran Immunosuppressive drugs for kidney transplantation N. Engl J. Med. 351 2004 2715 2729
3. E. Lazzeri P. Romagnani CXCR3-binding chemokines: novel multifunctional therapeutic targets Curr. Drug Targets Immune Endocr. Metabol. Disord. 5 2005 109 118
4. G. Tellides Th1 adaptive immune responses in cardiac graft arteriosclerosis: deleterious or beneficial? Circulation. 114 2006 1561 1564
5. A. Saiura T. Kohro T. Yamamoto A. Izumi Y. Wada H. Aburatani Y. Sugawara T. Hamakubo T. Taniguchi M. Naito T. Kodama M. Makuuchi Detection of an up-regulation of a group of chemokine genes in murine cardiac allograft in the absence of interferon-gamma by means of DNA microarray Transplantation 73 2002 1480 1486
6. J.J. Yun M.P. Fischbein D. Whiting Y. Irie M.C. Fishbein M.D. Burdick J. Belperio R.M. Strieter H. Laks J.A. Berliner A. Ardehali The role of MIG/CXCL9 in cardiac allograft vasculopathy Am. J. Pathol. 161 2002 1307 1313
7. M. Melter A. Exeni M.E. Reinders J.C. Fang G. McMahon P. Ganz W.W. Hancock D.M. Briscoe Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection Circulation 104 2001 2558 2564
8. D.X. Zhao Y. Hu G.G. Miller A.D. Luster R.N. Mitchell P. Libby Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection J. Immunol. 169 2002 1556 1560
9. W.W. Hancock W. Gao V. Csizmadia K.L. Faia N. Shemmeri A.D. Luster Donor-derived IP-10 initiates development of acute allograft rejection J. Exp. Med. 193 2001 975 980
10. W.W. Hancock B. Lu W. Gao V. Csizmadia K.L. Faia J.A. King S.T. Smiley M. Ling N.P. Gerard C. Gerard Requirement of the chemokine receptor CXCR3 for acute allograft rejection J. Exp. Med. 192 2000 1515 1520
11. T. El-Sawy N.M. Fahmy R.L. Fairchild Chemokines: directing leukocyte infiltration into allografts Curr. Opin. Immunol. 14 2002 562 568
12. R. Klingenberg F. Autschbach C. Gleissner T. Giese N. Wambsganss N. Sommer G. Richter H.A. Katus T.J. Dengler Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro Eur. J. Immunol. 35 2005 1712 1721
13. J.A. Balfour G.L. Plosker Rosiglitazone Drugs 57 1999 921 930
14. G. Villanueva D. Baldwin Rosiglitazone therapy of posttransplant diabetes mellitus Transplantation 80 2005 1402 1405
15. N. Marx F. Mach A. Sauty J.H. Leung M.N. Sarafi R.M. Ransohoff P. Libby J. Plutzky A.D. Luster Peroxisome proliferator-activated receptor- activators inhibit IFNγ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells J. Immunol. 164 2000 6503 6508
16. C. Crescioli L. Cosmi E. Borgogni V. Santarlasci S. Gelmini M. Sottili E. Sarchielli B. Mazzinghi M. Francalanci A. Pezzatini G. Perigli G.B. Vannelli F. Annunziato M. Serio Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes J. Endocrinol. 195 2007 145 155
17. − ΔΔCt method Methods 25 2001 402 408
18. S. Benvenuti R. Saccardi P. Luciani S. Urbani C. Deledda I. Cellai F. Francini R. Squecco F. Rosati G. Danza S. Gelmini I. Greeve M. Rossi R. Maggi M. Serio A. Peri Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1 Exp. Cell Res. 312 2006 2592 2604
19. L. Formigli F. Francini A. Tani R. Squecco D. Nosi L. Polidori S. Nistri L. Chiappini V. Cesati A. Pacini A.M. Perna G.E. Orlandini S. Zecchi-Orlandini D. Bani Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell–cell contacts and relaxin treatment Am. J. Physiol. Cell Physiol. 288 2005 795 804
20. G.B. Vannelli F. Ensoli R. Zonefrati Y. Kubota A. Arcangeli A. Becchetti G. Camici T. Barni C.J. Thiele G.C. Balboni Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors J. Neurosci 15 1995 4382 4394
21. L. Cosmi F. Annunziato M. Iwasaki G. Galli R. Manetti E. Maggi K. Nagata S. Romagnani CRTH2 is the most reliable marker for detection of human circulating Th2 and Tc2 cells in health and disease Eur. J. Immunol. 30 2000 2972 2979
22. low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors Circ. Res. 97 2005 314 322
23. A. De Lean P.J. Munson D. Rodbard Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose–response curves Am. J. Physiol. 235 1978 E97 E102
24. L. Sartiani E. Bettiol F. Stillitano A. Mugelli E. Cerbai M.E. Jaconi Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach Stem Cells 25 2007 1136 1144
25. M. Apkon J.M. Nerbonne Characterization of two distinct depolarization-activated K+ currents in isolated adult rat ventricular myocytes J. Gen. Physiol. 97 1991 973 1011
26. J.F. Heubach E.M. Graf J. Leutheuser M. Bock B. Balana I. Zahanich T. Christ S. Boxberger E. Wettwer U. Ravens Electrophysiological properties of human mesenchymal stem cells J. Physiol. 554 2004 659 672
27. W. Guo K. Kamiya J. Toyama Modulated expression of transient outward current in cultured neonatal rat ventricular myocytes: comparison with development in situ Cardiovasc. Res. 32 1996 524 533
28. A. Antonelli M. Rotondi S.M. Ferrari P. Fallahi P. Romagnani S.S. Franceschini M. Serio E. Ferrannini Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists J. Clin. Endocrinol. Metab. 91 2006 614 620
29. M. Rotondi A. Falorni A. De Bellis S. Laureti P. Ferruzzi P. Romagnani A. Buonamano E. Lazzeri C. Crescioli M. Mannelli F. Santeusanio A. Bellastella M. Serio Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines J. Clin. Endocrinol. Metab. 90 2005 2357 2363
30. A. Leri J. Kajstura P. Anversa Cardiac stem cells and mechanisms of myocardial regeneration Physiol. Rev. 85 2005 1373 1416
31. G. Vogel Cell biology. Stem cells: new excitement, persistent questions Science 290 2000 1672 1674
32. M.M. Davidson C. Nesti L. Palenzuela W.F. Walker E. Hernandez L. Protas M. Hirano N.D. Isaac Novel cell lines derived from adult human ventricular cardiomyocytes J. Mol. Cell Cardiol. 39 2005 133 147
33. Y.C. Wang N. Neckelmann A. Mayne A. Herskowitz A. Srinivasan K.W. Sell A. Ahmed-Ansari Establishment of a human fetal cardiac myocyte cell line In Vitro Cell. Dev. Biol. 27 1991 63 74
34. R. Li D. Mickle R. Weisel S. Carson S. Omar L.C. Tumiati G.J. Wilson W.G. Williams Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging Cardiovasc. Res. 32 1996 362 373
35. A.J. Ball F. Levine Telomere-independent cellular senescence in human fetal cardiomyocytes Aging Cell 4 2005 21 30
36. M.J. Patterson R.A. Kloner Flow cytometric analysis of S-phase DNA content in human fetal myocardium Card. Vasc. Regeneration 1 2000 92 96
37. T. Reffelmann J. Leor J. Muller-Ehmsen L. Kedes R.A. Kloner Cardiomyocyte transplantation into the failing heart—new therapeutic approach for heart failure? Heart Fail. Rev. 8 2003 201 211
38. J.D. Dowell M. Rubart K.B. Pasumarthi M.H. Soonpaa L.J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc. Res. 58 2003 336 350
39. M. Rubart K.B. Pasumarthi H. Nakajima M.H. Soonpaa H.O. Nakajima L.J. Field Physiological coupling of donor and host cardiomyocytes after cellular transplantation Circ. Res. 92 2003 1217 1224
40. R.P. Harvey Patterning the vertebrate heart Nat. Rev. Genet. 3 2002 544 556
41. K.L. Laugwitz A. Moretti J. Lam P. Gruber Y. Chen S. Woodard L.Z. Lin C.L. Cai M.M. Lu M. Reth O. Platoshyn J.X. Yuan S. Evans K.R. Chien Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages Nature 433 2005 647 653
42. P. Anversa J. Kajstura A. Leri R. Bolli Life and death of cardiac stem cells: a paradigm shift in cardiac biology Circulation 113 2006 1451 1463
43. A. Hirschy F. Schatzmann E. Ehler J.C. Perriard Establishment of cardiac cytoarchitecture in the developing mouse heart Dev. Biol. 289 2006 430 441
44. Z. Haskova A. Izawa A.G. Contreras E. Flynn G. Boulday D.M. Briscoe Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection Transplantation 83 2007 1595 1601
45. T. Krakauer J.J. Oppenheim IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1) J Immunol 150 1993 1205 1211
46. J.D. Campbell V. Gangur F.E. Simons K.T. HayGlass Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop FASEB J. 18 2004 329 331
47. P. Romagnani L. Lasagni F. Annunziato M. Serio S. Romagnani CXC chemokines: the regulatory link between inflammation and angiogenesis Trends Immunol 25 2004 201 209
48. C. Schmidt-Lucke A. Aicher P. Romagnani B. Gareis S. Romagnani A.M. Zeiher S. Dimmeler Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2425 H2431
49. J.A. Kobashigawa J.M. Tobis R.M. Mentzer H.A. Valantine R.C. Bourge M.R. Mehra F.W. Smart L.W. Miller K. Tanaka H. Li D.W. Gjertson R.D. Gordon Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial Am J Transplant. 6 2006 993 997
50. 2+-calcineurin-NFAT cascade in cardiac myocytes Cardiovasc. Res. 63 2004 450 457
51. O.F. Bueno E. van Rooij J.D. Molkentin P.A. Doevendans L.J. De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc. Res. 53 2002 806 821
52. Y. Chen Y. Liu Z. Yuan L. Tian M.J. Dallman P.W. Thompson P.K. Tam J.R. Lamb. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts Transplantation 83 2007 1602 1610
53. D. Choi S.K. Kim S.H. Choi Y.G. Ko C.W. Ahn Y. Jang S.K. Lim H.C. Lee B.S. Cha. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes Diabetes Care 27 2004 2654 2660
54. D.M. Nathan Rosiglitazone and cardiotoxicity—weighing the evidence N. Engl. J. Med. 357 2007 64 66
55. K. Kiryluk R. Isom Thiazolidinediones and fluid retention Kidney Int. 72 2007 762 768
56. A. Zanchi A. Chiolero M. Maillard J. Nussberger H.R. Brunner M. Burnier Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men J. Clin. Endocrinol. Metab. 89 2004 1140 1145
57. B. Dekel Y. Reisner Embryonic committed stem cells as a solution to kidney donor shortage Expert. Opin. Biol. Ther. 4 2004 443 454
58. R.P. Foglia J. DiPreta M.B. Statter PK. Donahoe Fetal allograft survival in immunocompetent recipients is age dependent and organ specific Ann. Surg. 204 1986 402 410